Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Lung Cancer

Free Subscription Articles published in Proc Natl Acad Sci U S A Retrieve available abstracts of 35 articles: HTML format

Single Articles

November 2022
1. LIU W, Tai CH, Liu X, Pastan I, et al
   Anti-mesothelin immunotoxin induces mesothelioma eradication, anti-tumor immunity, and the development of tertiary lymphoid structures.
   Proc Natl Acad Sci U S A. 2022;119:e2214928119.
   PubMed     Abstract available
   
   
   September 2022
2. ZHOU C, Wang D, Li J, Wang Q, et al
   TGFB2-AS1 inhibits triple-negative breast cancer progression via interaction with SMARCA4 and regulating its targets TGFB2 and SOX2.
   Proc Natl Acad Sci U S A. 2022;119:e2117988119.
   PubMed     Abstract available
   
   
   August 2022
3. WANG Z, Zhu J, Liu Y, Wang Z, et al
   Tumor-polarized GPX3(+) AT2 lung epithelial cells promote premetastatic niche formation.
   Proc Natl Acad Sci U S A. 2022;119:e2201899119.
   PubMed     Abstract available
   
   
   July 2022
4. BROWN BP, Zhang YK, Kim S, Finneran P, et al
   Allele-specific activation, enzyme kinetics, and inhibitor sensitivities of EGFR exon 19 deletion mutations in lung cancer.
   Proc Natl Acad Sci U S A. 2022;119:e2206588119.
   PubMed     Abstract available
   
   
   
5. WANG D, Wang Q, Wang Y, Chen P, et al
   Targeting oncogenic KRAS with molecular brush-conjugated antisense oligonucleotides.
   Proc Natl Acad Sci U S A. 2022;119:e2113180119.
   PubMed     Abstract available
   
   
   
6. MA L, Yang F, Wu X, Mao C, et al
   Structural basis and molecular mechanism of biased GPBAR signaling in regulating NSCLC cell growth via YAP activity.
   Proc Natl Acad Sci U S A. 2022;119:e2117054119.
   PubMed     Abstract available
   
   
   May 2022
7. 
   Retraction for Motiwala et al., Protein tyrosine phosphatase receptor-type O (PTPRO) exhibits characteristics of a candidate tumor suppressor in human lung cancer.
   Proc Natl Acad Sci U S A. 2022;119:e2200127119.
   PubMed    
   
   
   
8. SCHOLZ A, DeFalco J, Leung Y, Aydin IT, et al
   Mobilization of innate and adaptive antitumor immune responses by the RNP-targeting antibody ATRC-101.
   Proc Natl Acad Sci U S A. 2022;119:e2123483119.
   PubMed     Abstract available
   
   
   
9. FENG S, Callow MG, Fortin JP, Khan Z, et al
   A saturation mutagenesis screen uncovers resistant and sensitizing secondary KRAS mutations to clinical KRAS(G12C) inhibitors.
   Proc Natl Acad Sci U S A. 2022;119:e2120512119.
   PubMed     Abstract available
   
   
   April 2022
10. AHMED M, Kaur N, Cheng Q, Shanabrough M, et al
    A hypothalamic pathway for Augmentor alpha-controlled body weight regulation.
    Proc Natl Acad Sci U S A. 2022;119:e2200476119.
    PubMed     Abstract available
    
    
    February 2022
11. XU Q, Wang C, Zhou JX, Xu ZM, et al
    Loss of TET reprograms Wnt signaling through impaired demethylation to promote lung cancer development.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available
    
    
    
12. SONG NY, Li X, Ma B, Willette-Brown J, et al
    IKKalpha-deficient lung adenocarcinomas generate an immunosuppressive microenvironment by overproducing Treg-inducing cytokines.
    Proc Natl Acad Sci U S A. 2022;119.
    PubMed     Abstract available
    
    
    December 2021
13. SCHULT TA, Lauer MJ, Berker Y, Cardoso MR, et al
    Screening human lung cancer with predictive models of serum magnetic resonance spectroscopy metabolomics.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
14. ZHAO X, Hu J, Li Y, Guo M, et al
    Volumetric compression develops noise-driven single-cell heterogeneity.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    November 2021
15. CHEON H, Holvey-Bates EG, McGrail DJ, Stark GR, et al
    PD-L1 sustains chronic, cancer cell-intrinsic responses to type I interferon, enhancing resistance to DNA damage.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
16. DE S, Holvey-Bates EG, Mahen K, Willard B, et al
    The ubiquitin E3 ligase FBXO22 degrades PD-L1 and sensitizes cancer cells to DNA damage.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    September 2021
17. LLABATA P, Torres-Diz M, Gomez A, Tomas-Daza L, et al
    MAX mutant small-cell lung cancers exhibit impaired activities of MGA-dependent noncanonical polycomb repressive complex.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
18. 
    Correction for Jeon et al., A set of NF-kappaB-regulated microRNAs induces acquired TRAIL resistance in Lung cancer.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed    
    
    
    August 2021
19. MUELLER HS, Fowler CE, Dalin S, Moiso E, et al
    Acquired resistance to PRMT5 inhibition induces concomitant collateral sensitivity to paclitaxel.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    July 2021
20. SALMON M, Paniagua G, Lechuga CG, Fernandez-Garcia F, et al
    KRAS4A induces metastatic lung adenocarcinomas in vivo in the absence of the KRAS4B isoform.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
21. LIU Z, Wang F, Liu X, Sang Y, et al
    Cell membrane-camouflaged liposomes for tumor cell-selective glycans engineering and imaging in vivo.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    June 2021
22. ETXEBERRIA I, Bolanos E, Teijeira A, Garasa S, et al
    Antitumor efficacy and reduced toxicity using an anti-CD137 Probody therapeutic.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
23. SHI L, Tan X, Liu X, Yu J, et al
    Addiction to Golgi-resident PI4P synthesis in chromosome 1q21.3-amplified lung adenocarcinoma cells.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
24. SANCHEZ-RIVERA FJ, Ryan J, Soto-Feliciano YM, Clare Beytagh M, et al
    Mitochondrial apoptotic priming is a key determinant of cell fate upon p53 restoration.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    May 2021
25. PRADHAN AK, Maji S, Bhoopathi P, Talukdar S, et al
    Pharmacological inhibition of MDA-9/Syntenin blocks breast cancer metastasis through suppression of IL-1beta.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
26. DING Y, Liu Y, Lee DK, Tong Z, et al
    Cell lineage tracing links ERalpha loss in Erbb2-positive breast cancers to the arising of a highly aggressive breast cancer subtype.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
27. TIEN JC, Chugh S, Goodrum AE, Cheng Y, et al
    AGO2 promotes tumor progression in KRAS-driven mouse models of non-small cell lung cancer.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
28. WANG R, Godet I, Yang Y, Salman S, et al
    Hypoxia-inducible factor-dependent ADAM12 expression mediates breast cancer invasion and metastasis.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
29. TILSTON-LUNEL A, Mazzilli S, Kingston NM, Szymaniak AD, et al
    Aberrant epithelial polarity cues drive the development of precancerous airway lesions.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    April 2021
30. WAN PK, Tong KC, Lok CN, Zhang C, et al
    Platinum(II) N-heterocyclic carbene complexes arrest metastatic tumor growth.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    March 2021
31. YANG L, Yan X, Chen J, Zhan Q, et al
    Hexokinase 2 discerns a novel circulating tumor cell population associated with poor prognosis in lung cancer patients.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
32. BROWNLIE D, Scharenberg M, Mold JE, Hard J, et al
    Expansions of adaptive-like NK cells with a tissue-resident phenotype in human lung and blood.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    February 2021
33. JIMENEZ-SANCHEZ J, Bosque JJ, Jimenez Londono GA, Molina-Garcia D, et al
    Evolutionary dynamics at the tumor edge reveal metabolic imaging biomarkers.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    January 2021
34. CHIBAYA L, Karim B, Zhang H, Jones SN, et al
    Mdm2 phosphorylation by Akt regulates the p53 response to oxidative stress to promote cell proliferation and tumorigenesis.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    
    
35. XIAO Y, Lin FT, Lin WC
    ACTL6A promotes repair of cisplatin-induced DNA damage, a new mechanism of platinum resistance in cancer.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Lung Cancer is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: